secwatch / observer
8-K filed August 29, 2023, 7:59 PM ET ticker ELF CIK 0001600033
M&A confidence high sentiment positive materiality 0.90

e.l.f. Beauty to acquire skin care brand Naturium for $355M in cash and stock

e.l.f. Beauty, Inc.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.99

e.l.f. Beauty, Inc. entered into Securities Purchase Agreement with Naturium LLC, TCB-N Prelude Blocker Corp., The Center Brands LLC, Elaine J. Balady valued at $355.0 million total consideration, $72.02 million in stock (effective 2023-08-28).

Action
entry
Agreement
asset purchase
Counterparty
Naturium LLC, TCB-N Prelude Blocker Corp., The Center Brands LLC, Elaine J. Balady
Value
$355.0 million total consideration, $72.02 million in stock
Effective
2023-08-28
Exact text from the filing
On August 28, 2023 (the “ Signing Date ”), e.l.f. Beauty, Inc., a Delaware corporation (the “ Company ”), entered into a Securities Purchase Agreement (the “ Purchase Agreement ”) by and among the Company, Naturium LLC, a Delaware limited liability company (“ Naturium ”), TCB-N Prelude Blocker Corp., a Delaware limited liability company (“ Blocker ”), The Center Brands LLC, a Delaware limited liability company (“ TCB ”), Elaine J. Balady, an individual (together with TCB, the “ Naturium Sellers ”), TCB Prelude Holdings, LLC, a Delaware limited liability company (together with the Naturium Sellers, the “ Sellers ” and each, a “ Seller ”), e.l.f. Cosmetics, Inc., a Delaware corporation (“ e.l.f. Cosmetics ”), and TCB, in its capacity as the Sellers’ representative (the “ Representative ”).
View on SEC.gov

230 material agreements filed in the last 30 days. Browse all material agreements →

e.l.f. Beauty, Inc. filing history →

Source: SEC EDGAR
accession 0001193125-23-222959
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.